Breaking Finance News

Zacks Investment Research downgraded Merck & Co., Inc. (NYSE:MRK) to Hold in a statement released earlier today.

Zacks Investment Research has downgraded Merck & Co., Inc. (NYSE:MRK) to Hold in a statement released on 05/25/2017.

On 5/17/2017, Vetr Inc. released a statement on Merck & Co., Inc. (NYSE:MRK) upped the target price from $0.00 to $69.99 that suggested an upside of 0.11%.

Having a price of $64.74, Merck & Co., Inc. (NYSE:MRK) traded 1.54% higher on the day. With the last close up -12.67% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.02% over the same period. MRK has recorded a 50-day average of $63.99 and a two hundred day average of $63.61. Trade Volume was down over the average, with 4,893,367 shares of MRK changing hands under the typical 8,575,490

Recent Performance Chart

Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. has PE ratio of 30.08 with a one year low of $54.41 and a one year high of $66.80 and has a market cap of $0.

In addition to Zacks Investment Research reporting its target price, a total of 20 firms have reported on the stock. The consensus target price is $61.60 with 2 firms rating the stock a strong buy, 7 firms rating the stock a buy, 13 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *